A toric multifocal IOL yielded significantly less residual corneal astigmatism than a non-toric multifocal IOL combined with peripheral corneal relaxing incisions, according to a study. Both methods ...

Please provide your email address to receive an email when new articles are posted on . With advancing technology, cataract surgery is now less invasive, resulting in better recovery and outcomes. Not ...

SALT LAKE CITY, UT--(Marketwired - Jun 14, 2017) - In March 2017, the U.S. Food and Drug Administration approved a new, advanced intraocular lens implant (IOL) called the Acrysof IQ ReSTOR® +2.5 ...

Basel, March 23, 2017 - Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof® IQ ReSTOR® +2.5 ...

The US Food and Drug Administration (FDA) has approved a new intraocular lens (IOL) designed to address presbyopia and pre-existing corneal astigmatism at the time of cataract surgery in adults. The ...

Novartis International AG / Alcon receives US FDA approval for new AcrySof® IQ ReSTOR® +2.5 Multifocal Toric IOL with ACTIVEFOCUS design for uncompromised distance vision and presbyopia correction .

Alcon, the global leader in eye care and a division of Novartis, has received approval from the US Food and Drug Administration (FDA) for its AcrySof IQ ReSTOR +2.5 Multifocal Toric intraocular lens ...